↓ Skip to main content

Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans

Overview of attention for article published in Frontiers in Pharmacology, March 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
7 news outlets
twitter
19 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans
Published in
Frontiers in Pharmacology, March 2019
DOI 10.3389/fphar.2019.00196
Pubmed ID
Authors

Sam Salek, Sarah Lussier Hoskyn, Jeffrey Roy Johns, Nicola Allen, Chander Sehgal

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Bachelor 7 14%
Researcher 5 10%
Student > Ph. D. Student 5 10%
Other 3 6%
Other 7 14%
Unknown 14 28%
Readers by discipline Count As %
Medicine and Dentistry 9 18%
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Nursing and Health Professions 4 8%
Agricultural and Biological Sciences 3 6%
Unspecified 3 6%
Other 10 20%
Unknown 15 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 67. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#635,898
of 25,400,630 outputs
Outputs from Frontiers in Pharmacology
#221
of 19,754 outputs
Outputs of similar age
#14,594
of 364,031 outputs
Outputs of similar age from Frontiers in Pharmacology
#5
of 340 outputs
Altmetric has tracked 25,400,630 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,754 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,031 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 340 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.